RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Cetuximab Fails to Extend OS in Locally Advanced Esophageal Cancer
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 22
SP 12
OP 12
DO 10.1177/155989771422007
UL http://mdc.sagepub.com/content/14/22/12.1.abstract
AB Cetuximab plus chemotherapy and radiation therapy does not improve clinical complete response rates or overall survival (OS) in patients with locally advanced esophageal cancer. This article presents data from the Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer trial [RTOG 0436; Ilson D et al. Ann Oncol 2014 (abstr O-0005)].